Maris Gunars Hartmanis

Maris Gunars Hartmanis currently works at Hartmanis & Partners AB, as Chairman & Chief Executive Officer, Fingers Brain Health Institute, as Chairman & Chief Executive Officer, and Royal Institute of Technology, as Associate Professor from 1987.
Dr. Hartmanis also formerly worked at BioPhausia AB, as Chief Executive Officer from 2010 to 2014, Medivir AB, as President & Chief Executive Officer from 2012 to 2014, Pronova AS, as Vice Chairman from 2006 to 2017, Xspray Pharma AB, as Director, Vitrolife AB, as Director from 2008 to 2015, Dynal Biotech AS, as Director, Cross Pharma AB, as Director, Karolinska Institutet Innovations AB, as Director from 2016 to 2017, Applied Photophysics Ltd., as Director from 2015 to 2018, Xbrane Biopharma AB, as Independent Director from 2015 to 2020, BioLamina AB, as Director from 2016 to 2022, Medivir Personal AB, as Director from 2011 to 2014, Altesse I örnsköldsvik AB, as Director, Glycovisc BioTech AB, as Director, Astor Pharma AB, as Director, and Gambro AB, as Chief Scientific Officer.
Dr. Hartmanis received his doctorate degree from Royal Institute of Technology.